Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2466
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial ; volume:15 ; number:1 ; day:6 ; month:5 ; year:2015 ; pages:1-10 ; date:12.2015
BMC pulmonary medicine ; 15, Heft 1 (6.5.2015), 1-10, 12.2015
- Creator
-
Rottenkolber, Marietta
- Contributor
-
Fischer, Rainald
Ibáñez, Luisa
Fortuny, Joan
Reynolds, Robert
Amelio, Justyna
Gerlach, Roman
Tauscher, Martin
Thürmann, Petra A.
Hasford, Joerg
Schmiedl, Sven
SpringerLink (Online service)
- DOI
-
10.1186/s12890-015-0051-x
- URN
-
urn:nbn:de:1111-2016110923799
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rottenkolber, Marietta
- Fischer, Rainald
- Ibáñez, Luisa
- Fortuny, Joan
- Reynolds, Robert
- Amelio, Justyna
- Gerlach, Roman
- Tauscher, Martin
- Thürmann, Petra A.
- Hasford, Joerg
- Schmiedl, Sven
- SpringerLink (Online service)
Other Objects (12)
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Prescribing practices of inhaled corticosteroids for premature infants in the neonatal intensive care unit
Primary care cohort study in the sequence of diagnosing chronic respiratory diseases and prescribing inhaled corticosteroids
Comment on: “Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists”
Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
Overuse of Oral Corticosteroids, Underuse of Inhaled Corticosteroids, and Implications for Biologic Therapy in Asthma
Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids
Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients with COPD: Pooled Results of Randomized Placebo-Controlled Trials
Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Prescribing practices of inhaled corticosteroids for premature infants in the neonatal intensive care unit
Primary care cohort study in the sequence of diagnosing chronic respiratory diseases and prescribing inhaled corticosteroids
Comment on: “Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists”
Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
Overuse of Oral Corticosteroids, Underuse of Inhaled Corticosteroids, and Implications for Biologic Therapy in Asthma
Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids
Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients with COPD: Pooled Results of Randomized Placebo-Controlled Trials
Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Prescribing practices of inhaled corticosteroids for premature infants in the neonatal intensive care unit
Primary care cohort study in the sequence of diagnosing chronic respiratory diseases and prescribing inhaled corticosteroids
Comment on: “Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists”
Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
Overuse of Oral Corticosteroids, Underuse of Inhaled Corticosteroids, and Implications for Biologic Therapy in Asthma
Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids
Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients with COPD: Pooled Results of Randomized Placebo-Controlled Trials